Osoresnontrine Uses, Dosage, Side Effects and more
Osoresnontrine is under investigation in clinical trial NCT02281773 (A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.).
| Trade Name | Osoresnontrine |
| Generic | Osoresnontrine |
| Osoresnontrine Other Names | Osoresnontrine |
| Type | |
| Formula | C16H17N5O2 |
| Weight | Average: 311.345 Monoisotopic: 311.138224807 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
